SEC Form 4 · accession 0001104659-16-163180
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger J. Waltzman
Officer — Chief Scientific Officer
Period of report
Dec 19, 2016
Accepted (ET)
Dec 21, 2016 · 2:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $0.74 | Dec 19, 2016 | A | 2,866 | A | — | Dec 19, 2026 | Common Stock | 2,866 | 2,866 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan.
- F2Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date.